A Study of Intermittent Oral Dosing of ASP1517 in Peritoneal Dialysis Chronic Kidney Disease Patients With Anemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The objective of this study is to evaluate the safety and efficacy of ASP1517 in peritoneal dialysis chronic kidney disease patients with anemia.
Epistemonikos ID: db5c6a8b792ae1ce662484a4c0b055d2b46b1330
First added on: May 13, 2024